Astera Labs, Inc. ALAB
Nasdaq
Misaligned: insiders net sellers over 24 months, price 986% above insider cost
Current directors and officers hold 20.30% of shares outstanding, worth $13.76B at $390.88. Over the last 24 months insiders bought $0.00 in the open market and sold $392.97M outside 10b5-1 plans and $1.17B under them. The stock trades 986% above the average price insiders paid in the open market.
Component breakdown
Skin in the game 20 / 20
How much the CEO and the insider group own, measured from their own Form 4 holdings.
A metric here is not applicable, so this component was rescaled to preserve its weight.
| CEO stake as a multiple of cash pay A1 | N/A, component rescaled | N/A |
|---|---|---|
| Insider group ownership A2 | See the value and its source | 8 / 8 |
Bought, not granted 5 / 15
Whether insiders put their own money in through open-market purchases, or only hold what they were awarded.
| CEO shares bought in the open market B1 | See the value and its source | 0 / 8 |
|---|---|---|
| Insiders who bought in the open market B2 | See the value and its source | 5 / 7 |
Above or below water 12 / 30
Where today's price sits against what insiders paid in the open market, and whether they still hold those shares. A price below insider cost is a better entry than insiders got.
| Price versus insider purchase cost W1 Free preview | 985.78% More than 75% above insider cost | 0 / 18 |
|---|---|---|
| Purchased shares still held W2 | See the value and its source | 12 / 12 |
Recent buying trends 5.7 / 25
Over the last 24 months: are insiders net buyers or sellers, how many bought together, and how recently.
A metric here is not applicable, so this component was rescaled to preserve its weight.
| Net insider buying C1 | See the value and its source | 5 / 10 |
|---|---|---|
| Option exercises sold the same day C2 | N/A, component rescaled | N/A |
| Conviction buying C3 | See the value and its source | 0 / 5 |
| Officer sales outside 10b5-1 plans C4 | See the value and its source | 0 / 3 |
| Most recent open-market purchase C5 | See the value and its source | 0 / 4 |
Dilution cost 6 / 10
How much equity compensation costs outside shareholders, from the company's XBRL financial data.
| Stock-based compensation versus market value F1 | See the value and its source | 6 / 6 |
|---|---|---|
| Diluted share count growth F2 | See the value and its source | 0 / 4 |
See the filings and arithmetic behind each part of ALAB's score.
Free with your email.
One email address, no password. We'll send a sign-in link so you can get back in later.
Key insiders
| Name | Role | Owned | Multiple | Bought | 24-month activity |
|---|---|---|---|---|---|
| Mohan Jitendra | Chief Executive Officer and Director | $3.1B | — | 0% | −$134M outside a plan −$331M under a plan |
| Gajendra Sanjay | President and COO and Director | $3.0B | — | 0% | −$134M outside a plan −$429M under a plan |
| Tate Michael Truett | Chief Financial Officer | $254M | — | 0% | −$75.1M outside a plan −$89.3M under a plan |
| Mazzara Philip | General Counsel and Secretary | $37.7M | — | 0% | −$8.6M outside a plan −$21.9M under a plan |
| Lynch Desmond | Chief Financial Officer | $19.4M | — | 0% | No activity |
| Cota Germaine | Chief Accting. Off. & VP, Fin. | $10.3M | — | 0% | No activity |
| Dyckerhoff Stefan A | Director | $6.7B | — | 0% | −$42.0M outside a plan −$24.4M under a plan |
| ALBA MANUEL | Director | $542M | — | 0% | −$255M under a plan |
| HURLSTON MICHAEL E. | Director | $36.1M | — | 24% | −$7.2M under a plan |
| LAZAR JACK R | Director | $29.6M | — | 13% | −$11.0M under a plan |
| BARRATT CRAIG H | Director | $2.7M | — | 0% | No activity |
| Mayer Bethany | Director | $2.5M | — | 0% | −$331K under a plan |
| All current directors and officers | 20.30% of shares outstanding | $13.8B | — | — | — |
Directors and officers who filed a Form 4 in the last 24 months. Owned is each person's latest reported non-derivative holdings (direct plus each indirect line, no options) at the price above. Multiple is the CEO's holdings divided by salary, bonus, and non-equity incentive from the latest proxy. Bought is the share of current holdings bought in the open market in the last five years.
Insider activity
Full activity24 months to Oct 06, 2026. Grants and shares withheld for tax are excluded: they are not decisions to buy or sell.
| Date | Insider | Transaction | Shares | Price | Value | Plan |
|---|---|---|---|---|---|---|
| Sep 02, 2026 | Dyckerhoff Stefan A | Sale under a 10b5-1 plan | 32 | $276.75 | $8.9K | 10b5-1 |
| Sep 02, 2026 | Dyckerhoff Stefan A | Sale under a 10b5-1 plan | 407 | $276.75 | $113K | 10b5-1 |
| Sep 02, 2026 | Dyckerhoff Stefan A | Sale under a 10b5-1 plan | 172 | $276.75 | $47.6K | 10b5-1 |
See every insider trade at ALAB, classified by type.
Free with your email.
One email address, no password. We'll send a sign-in link so you can get back in later.
What insiders paid
Insider by insider3 insiders are sitting on a gain of $8.2M on the shares they bought in the open market (618.6% above what they paid)
Open-market purchases (Form 4 code P) in the five years to Oct 06, 2026, valued at $258.70 on Oct 31, 2026. Grants are excluded: they cost the insider nothing. Shares an insider has since sold are not counted — each person's purchases are capped at what they most recently reported holding, at their own average price paid. The score's "Above or below water" component is computed from these figures at the score's price, where a price below insider cost scores higher.
Score history
Full changelog- Oct 06, 2026 full grade no change Score up 0.0 to 48.7 after new filings or prices.
- Oct 05, 2026 full grade First automated score: 48.7 (Misaligned).
Peer context
Sources
All sources- XBRL financial data 10-Q filed 2026-08-05 View on EDGAR
- Latest of 183 Form 4 filings 4 filed 2026-09-03 View on EDGAR